Autolus Therapeutics (AUTL) Market Capitalization (2018 - 2026)
Analysis
Autolus Therapeutics (AUTL) Market Capitalization (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Autolus Therapeutics | 594.86 Mn | 393.23 Mn | 25.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 568.07 Mn |
| Dec 31, 2025 | 706.52 Mn |
| Sep 30, 2025 | 578.71 Mn |
| Jun 30, 2025 | 809.47 Mn |
| Mar 31, 2025 | 550.36 Mn |
| Dec 31, 2024 | 834.37 Mn |
| Sep 30, 2024 | 1.29 Bn |
| Jun 30, 2024 | 1.24 Bn |
| Mar 31, 2024 | 2.26 Bn |
| Dec 31, 2023 | 1.69 Bn |
| Sep 30, 2023 | 612.47 Mn |
| Jun 30, 2023 | 625.01 Mn |
| Mar 31, 2023 | 482.08 Mn |
| Dec 31, 2022 | 497.80 Mn |
| Sep 30, 2022 | 385.33 Mn |
| Jun 30, 2022 | 508.94 Mn |
| Mar 31, 2022 | 749.92 Mn |
| Dec 31, 2021 | 933.35 Mn |
| Sep 30, 2021 | 925.35 Mn |
| Jun 30, 2021 | 938.06 Mn |